Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

This publication has 26 references indexed in Scilit:

• Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials
  BMJ, 2007
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
  Circulation, 2006
• Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide
  Journal of the American College of Cardiology, 2006
• Predictors and 1-year outcome of major bleeding in patients with non–ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome Registries
  American Heart Journal, 2005
• Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes
  The American Journal of Cardiology, 2005
• Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
  European Heart Journal, 2005
• Validity of composite end points in clinical trials
  BMJ, 2005
• Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel
  Circulation, 2004
• A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries
  Journal of Internal Medicine, 2004
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
  Circulation, 2004